Methods of Treating Cytokine Mediated Diseases

MOSS NEIL, REGAN JOHN R
2007
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-09-17 ⓘ

Aromatic heterocyclic compounds described in WO 00/55139 are disclosed for treating cytokine-mediated diseases including endometriosis, acute and chronic lung inflammation from smoke inhalation, Behcet's disease, uveitis, ankylosing spondylitis, pancreatitis, cancer, Lyme disease, sepsis, COPD, traumatic arthritis, congestive heart failure, and restenosis following percutaneous transluminal coronary angioplasty.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Disclosed are methods of treating acute and chronic inflammation in the lung caused by inhalation of smoke, endometriosis, Behcet's disease, uveitis, ankylosing spondylitis, pancreatitis, cancer, Lyme disease, sepsis, chronic obstructive pulmonary disease, traumatic arthritis, congestive heart failure and restenosis following percutaneous transluminal coronary angioplasty, known to be cytokine mediated, using aromatic heterocyclic compounds described in WO 00/55139.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00